LENZ
LENZ TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
LENZ vs peer average
71/100
LENZ vs. peer average (B vs. C)
Grade spread
A 1 · B 3 · D 4 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AUTL is the first available peer comparator.
Autolus: similar small-cap biopharma with active clinical programs and commercialization transition risk; useful operational comparator for trial-to-market cadence.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LENZ
LENZ Therapeutics
AUTL
Autolus Therapeutics
Grade
B
A
Momentum
2
94
Value
57
41
Sentiment
100
56
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs AUTL
LENZ / AUTL
Grade Position
Above peers
LENZ vs. peer average (B vs. C)
71/100
Momentum
2
AUTLValue
57
LENZSentiment
100
LENZRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LENZ
AUTL is the first peer returned for this comparison set.

